Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Expression Vector Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's offering.
This market research publication reveals an in-depth analysis of the Global Expression Vector Market over the next decade, projecting a CAGR growth of 5.10% from 2018 until 2028. The expression vector market, vital for gene delivery in gene therapy and biopharmaceutical production, was valued at USD 440.50 million in 2022 and is expected to see substantial growth in the forecast period.
In the realm of biotechnology, expression vectors play a pivotal role as DNA molecules engineered to express specific genes within various host cells. These vectors contain critical components such as a promoter region and an origin of replication, facilitating the production and propagation of proteins or gene products crucial for numerous applications including research, therapeutic, and vaccine development.
Key Market Drivers and Trends
The expansion of the expression vector market is driven by several key factors:
- Gene Therapy Expansion: As gene therapy becomes more widespread, the need for precision vectors for delivering therapeutic genes is surging, especially given the increased focus on treatments for cancer, genetic disorders, and rare diseases.
- Technological Advancements: Innovations in vector technology and host cell systems are enhancing recombinant protein expression levels, advancing gene-editing techniques like CRISPR-Cas9, and promoting developments in viral vectors.
- Rise in Vaccine Development: With the recent success of mRNA vaccines, the demand for efficient expression systems is accelerating, fostering rapid antigen production for a growing array of infectious diseases and therapeutic vaccines.
Market Challenges
The industry faces significant challenges, including concerns about the safety and environmental impact of expression vectors, but advancements in biocontainment and green bioprocessing practices are helping to address these issues.
Market Segmentation Insights
Segmental analysis provides valuable insights into various components of the expression vector industry:
- Host Type Insights: Bacterial expression vectors lead the market, praised for their expediency and simplicity in producing high quantities of proteins.
- Application Insights: Therapeutic applications dominate due to the escalating number of gene therapy trials, reliance on biotherapeutics, and personalized medicine trends.
- End-User Insights: Pharmaceutical & biotech companies constitute the largest end-user segment, leveraging expression vectors in the development of gene therapies and vaccines.
Regional Market Insights
The North American region claims the largest market share, propelled by substantial investments, the presence of industry leaders, and numerous clinical trials taking place in the region.
The extensive review of the expression vector industry underscores the technology’s critical importance in health innovations and its promising growth trajectory. The comprehensive analysis of market drivers, trends, challenges, and segment insights serves as a valuable resource for stakeholders navigating the dynamic landscape of biotechnology.
Competitive Landscape
In a highly competitive market, companies engaged in the expression vector space face the dual challenge of innovative and safe product development while maintaining profitability and compliance with regulatory standards. With intense market competition and the push for technological advancements, businesses are poised to emerge stronger in delivering valuable solutions in gene therapy and related fields.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2023-2028 |
| Estimated Market Value (USD) in 2023 | $440.5 Million |
| Forecasted Market Value (USD) by 2028 | $590.01 Million |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes:
- Thermo Fisher Scientific, Inc.
- Promega Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Merck KGaA
- TAKARA HOLDINGS Inc.
- GenScript Corp.
- Quest Diagnostics
- Addgene, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/w3wxge
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
